Radiogenomics: what it is and why it is important. Maciej A Mazurowski. J Am Coll Radiol, 2015 Aug 08; 12(8). PMID: 26250979 Highly Cited.
|
A Validated Model for Identifying Patients Unlikely to Benefit From the 21-Gene Recurrence Score Assay. Michele M Gage, Martin Rosman, +6 authors, W Charles Mylander, Erica Giblin, Hyun-Seok Kim, Leslie Cope, Christopher Umbricht, Antonio C Wolff, Lorraine Tafra. less Clin Breast Cancer, 2015 Jun 15; 15(6). PMID: 26072275 Free PMC article.
|
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. A S Coates, E P Winer, +6 authors, A Goldhirsch, R D Gelber, M Gnant, M Piccart-Gebhart, B Thürlimann, H-J Senn, Panel Members. less Ann Oncol, 2015 May 06; 26(8). PMID: 25939896 Free PMC article. Highly Cited.
|
Radiomic analysis reveals DCE-MRI features for prediction of molecular subtypes of breast cancer. Ming Fan, Hui Li, +3 authors, Shijian Wang, Bin Zheng, Juan Zhang, Lihua Li. less PLoS One, 2017 Feb 07; 12(2). PMID: 28166261 Free PMC article.
|
Prediction of the Oncotype DX recurrence score: use of pathology-generated equations derived by linear regression analysis. Molly E Klein, David J Dabbs, +4 authors, Yongli Shuai, Adam M Brufsky, Rachel Jankowitz, Shannon L Puhalla, Rohit Bhargava. less Mod Pathol, 2013 Mar 19; 26(5). PMID: 23503643 Free PMC article.
|
A lower Allred score for progesterone receptor is strongly associated with a higher recurrence score of 21-gene assay in breast cancer. Ping Tang, Jianmin Wang, +9 authors, David G Hicks, Xi Wang, Linda Schiffhauer, Loralee McMahon, Qi Yang, Michelle Shayne, Alissa Huston, Kristin A Skinner, Jennifer Griggs, Gary Lyman. less Cancer Invest, 2010 Aug 10; 28(9). PMID: 20690804
|
Analysis of the MammaPrint breast cancer assay in a predominantly postmenopausal cohort. Ben S Wittner, Dennis C Sgroi, +9 authors, Paula D Ryan, Tako J Bruinsma, Annuska M Glas, Anitha Male, Sonika Dahiya, Karleen Habin, Rene Bernards, Daniel A Haber, Laura J Van't Veer, Sridhar Ramaswamy. less Clin Cancer Res, 2008 May 17; 14(10). PMID: 18483364 Free PMC article.
|
Interobserver variability in identification of breast tumors in MRI and its implications for prognostic biomarkers and radiogenomics. Ashirbani Saha, Lars J Grimm, +4 authors, Michael Harowicz, Sujata V Ghate, Connie Kim, Ruth Walsh, Maciej A Mazurowski. less Med Phys, 2016 Aug 05; 43(8). PMID: 27487872
|
Radiomics: Images Are More than Pictures, They Are Data. Robert J Gillies, Paul E Kinahan, Hedvig Hricak. Radiology, 2015 Nov 19; 278(2). PMID: 26579733 Free PMC article. Highly Cited.
|
N4ITK: improved N3 bias correction. Nicholas J Tustison, Brian B Avants, +4 authors, Philip A Cook, Yuanjie Zheng, Alexander Egan, Paul A Yushkevich, James C Gee. less IEEE Trans Med Imaging, 2010 Apr 10; 29(6). PMID: 20378467 Free PMC article. Highly Cited.
|
Breast cancer subtype intertumor heterogeneity: MRI-based features predict results of a genomic assay. Elizabeth J Sutton, Jung Hun Oh, +5 authors, Brittany Z Dashevsky, Harini Veeraraghavan, Aditya P Apte, Sunitha B Thakur, Joseph O Deasy, Elizabeth A Morris. less J Magn Reson Imaging, 2015 Apr 09; 42(5). PMID: 25850931 Free PMC article. Highly Cited.
|
Comparison of PAM50 risk of recurrence score with oncotype DX and IHC4 for predicting risk of distant recurrence after endocrine therapy. Mitch Dowsett, Ivana Sestak, +7 authors, Elena Lopez-Knowles, Kalvinder Sidhu, Anita K Dunbier, J Wayne Cowens, Sean Ferree, James Storhoff, Carl Schaper, Jack Cuzick. less J Clin Oncol, 2013 Jul 03; 31(22). PMID: 23816962 Highly Cited.
|
Radiogenomic analysis of breast cancer: luminal B molecular subtype is associated with enhancement dynamics at MR imaging. Maciej A Mazurowski, Jing Zhang, +2 authors, Lars J Grimm, Sora C Yoon, James I Silber. less Radiology, 2014 Jul 17; 273(2). PMID: 25028781 Highly Cited.
|
Algorithms for prediction of the Oncotype DX recurrence score using clinicopathologic data: a review and comparison using an independent dataset. Michael R Harowicz, Timothy J Robinson, +4 authors, Michaela A Dinan, Ashirbani Saha, Jeffrey R Marks, P Kelly Marcom, Maciej A Mazurowski. less Breast Cancer Res Treat, 2017 Jan 09; 162(1). PMID: 28064383 Free PMC article.
|
Quantitative MRI radiomics in the prediction of molecular classifications of breast cancer subtypes in the TCGA/TCIA data set. Hui Li, Yitan Zhu, +13 authors, Elizabeth S Burnside, Erich Huang, Karen Drukker, Katherine A Hoadley, Cheng Fan, Suzanne D Conzen, Margarita Zuley, Jose M Net, Elizabeth Sutton, Gary J Whitman, Elizabeth Morris, Charles M Perou, Yuan Ji, Maryellen L Giger. less NPJ Breast Cancer, 2016 Nov 18; 2. PMID: 27853751 Free PMC article. Highly Cited.
|
A Radio-genomics Approach for Identifying High Risk Estrogen Receptor-positive Breast Cancers on DCE-MRI: Preliminary Results in Predicting OncotypeDX Risk Scores. Tao Wan, B Nicolas Bloch, +5 authors, Donna Plecha, CheryI L Thompson, Hannah Gilmore, Carl Jaffe, Lyndsay Harris, Anant Madabhushi. less Sci Rep, 2016 Feb 19; 6. PMID: 26887643 Free PMC article.
|
Triple-negative breast cancer: correlation between MR imaging and pathologic findings. Takayoshi Uematsu, Masako Kasami, Sachiko Yuen. Radiology, 2009 Feb 27; 250(3). PMID: 19244039
|
Identifying relations between imaging phenotypes and molecular subtypes of breast cancer: Model discovery and external validation. Jia Wu, Xiaoli Sun, +5 authors, Jeff Wang, Yi Cui, Fumi Kato, Hiroki Shirato, Debra M Ikeda, Ruijiang Li. less J Magn Reson Imaging, 2017 Feb 09; 46(4). PMID: 28177554 Free PMC article.
|
Stability of FDG-PET Radiomics features: an integrated analysis of test-retest and inter-observer variability. Ralph T H Leijenaar, Sara Carvalho, +9 authors, Emmanuel Rios Velazquez, Wouter J C van Elmpt, Chintan Parmar, Otto S Hoekstra, Corneline J Hoekstra, Ronald Boellaard, André L A J Dekker, Robert J Gillies, Hugo J W L Aerts, Philippe Lambin. less Acta Oncol, 2013 Sep 21; 52(7). PMID: 24047337 Free PMC article. Highly Cited.
|
A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer. Torsten O Nielsen, Joel S Parker, +12 authors, Samuel Leung, David Voduc, Mark Ebbert, Tammi Vickery, Sherri R Davies, Jacqueline Snider, Inge J Stijleman, Jerry Reed, Maggie C U Cheang, Elaine R Mardis, Charles M Perou, Philip S Bernard, Matthew J Ellis. less Clin Cancer Res, 2010 Sep 15; 16(21). PMID: 20837693 Free PMC article. Highly Cited.
|
Computer-aided Diagnosis-generated Kinetic Features of Breast Cancer at Preoperative MR Imaging: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer. Jin Joo Kim, Jin You Kim, +4 authors, Hyun Jung Kang, Jong Ki Shin, Taewoo Kang, Seok Won Lee, Young Tae Bae. less Radiology, 2017 Mar 03; 284(1). PMID: 28253106
|
Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer. Soonmyung Paik, Gong Tang, +11 authors, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L Baehner, Drew Watson, John Bryant, Joseph P Costantino, Charles E Geyer, D Lawrence Wickerham, Norman Wolmark. less J Clin Oncol, 2006 May 25; 24(23). PMID: 16720680 Highly Cited.
|
Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms. Maciej A Mazurowski, Lars J Grimm, +5 authors, Jing Zhang, P Kelly Marcom, Sora C Yoon, Connie Kim, Sujata V Ghate, Karen S Johnson. less Eur J Radiol, 2015 Jul 27; 84(11). PMID: 26210095
|
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. Soonmyung Paik, Steven Shak, +12 authors, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park, William Hiller, Edwin R Fisher, D Lawrence Wickerham, John Bryant, Norman Wolmark. less N Engl J Med, 2004 Dec 14; 351(27). PMID: 15591335 Highly Cited.
|
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. E R DeLong, D M DeLong, D L Clarke-Pearson. Biometrics, 1988 Sep 01; 44(3). PMID: 3203132 Highly Cited.
|
MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays. Hui Li, Yitan Zhu, +13 authors, Elizabeth S Burnside, Karen Drukker, Katherine A Hoadley, Cheng Fan, Suzanne D Conzen, Gary J Whitman, Elizabeth J Sutton, Jose M Net, Marie Ganott, Erich Huang, Elizabeth A Morris, Charles M Perou, Yuan Ji, Maryellen L Giger. less Radiology, 2016 Oct 19; 281(2). PMID: 27144536 Free PMC article. Highly Cited.
|
NSABP study confirms oncotype DX predicts chemotherapy benefit in breast cancer patients. Oncology (Williston Park), 2006 Jul 18; 20(7). PMID: 16841801
|
Identification of intrinsic imaging phenotypes for breast cancer tumors: preliminary associations with gene expression profiles. Ahmed Bilal Ashraf, Dania Daye, +4 authors, Sara Gavenonis, Carolyn Mies, Michael Feldman, Mark Rosen, Despina Kontos. less Radiology, 2014 Apr 08; 272(2). PMID: 24702725 Free PMC article.
|
MRI phenotype of breast cancer: Kinetic assessment for molecular subtypes. Eric Blaschke, Hiroyuki Abe. J Magn Reson Imaging, 2015 Mar 12; 42(4). PMID: 25758675
|
Can signal enhancement ratio (SER) reduce the number of recommended biopsies without affecting cancer yield in occult MRI-detected lesions? Vignesh A Arasu, Ryan C-Y Chen, +4 authors, David N Newitt, C Belinda Chang, Hilda Tso, Nola M Hylton, Bonnie N Joe. less Acad Radiol, 2011 Mar 23; 18(6). PMID: 21420333 Free PMC article.
|